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Accelerated aging syndromes represent a valuable source of information about the molecular mechanisms involved in normal aging.
Here, we describe a progeroid syndrome that partially phenocopies Hutchinson-Gilford progeria syndrome (HGPS) but also exhibits
distinctive features, including the absence of cardiovascular deficiencies characteristic of HGPS, the lack of mutations in LMNA and
ZMPSTE24, and a relatively long lifespan of affected individuals. Exome sequencing and molecular analysis in two unrelated families
allowed us to identify a homozygous mutation in BANF1 (c.34G>A [p.Ala12Thr]), encoding barrier-to-autointegration factor 1 (BAF),
as the molecular abnormality responsible for this Mendelian disorder. Functional analysis showed that fibroblasts from both patients
have a dramatic reduction in BAF protein levels, indicating that the p.Ala12Thr mutation impairs protein stability. Furthermore,
progeroid fibroblasts display profound abnormalities in the nuclear lamina, including blebs and abnormal distribution of emerin, an
interaction partner of BAF. These nuclear abnormalities are rescued by ectopic expression of wild-type BANF1, providing evidence for
the causal role of this mutation. These data demonstrate the utility of exome sequencing for identifying the cause of rare Mendelian
disorders and underscore the importance of nuclear envelope alterations in human aging.Aging is a very complex process that affects most biological
functions of the organism, but its molecular basis remain
largely unknown.1 Over the last few years, our knowledge
of the molecular mechanisms underlying human aging
has gained new insights from studies on premature aging
syndromes that cause the early development of multiple
phenotypes normally associated with advanced age.2,3
Most of these human progeroid syndromes are caused by
defects in DNA repair systems, but recent studies have
shown that alterations in nuclear envelope formation
and dynamics are involved in the development of acceler-
ated aging syndromes.4 Thus, patients with Hutchinson-
Gilford progeria syndrome (HGPS [MIM 176670]) carry
mutations in LMNA (MIM 150330), which encodes two
major components of the nuclear envelope, the lamins
A and C.5,6 In addition, other progeroid syndromes, such
as restrictive dermopathy (RD [MIM 275210]) and mandi-
buloacral dysplasia (MADB [MIM 608612]), are caused by
mutations in ZMPSTE24 (also known as FACE1 [MIM
606480]),7,8 which encodes a metalloprotease involved in
prelamin A maturation.9 However, there may still be other
classes of genetic mutations responsible for the develop-
ment of accelerated aging in patients who lack mutations
in all previously described genes associated with these
devastating diseases.
The recent availability of high-throughput sequencing
technologies has now made it feasible to address personal
genome projects that could uncover the precise genetic
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fully used to identify mutations responsible for genetic
disorders of unknown cause.12–15 In this work, we have
used this approach to identify the disease-causing muta-
tions in patients who were originally diagnosed with
a progeroid syndrome that phenocopies features of HGPS
and mandibuloacral dysplasia but whose mutational
analysis of candidate genes did not reveal any change in
LMNA or ZMPSTE24.
To gain insights into the molecular mechanisms impli-
cated in putative accelerated aging, we studied patients
with progeroid syndromes without mutations in known
candidate genes. Affected individuals are members of two
unrelated Spanish families, from distant regions of the
country (family A is from Gran Canaria; family B is from
Castilla). DNA samples were isolated fromperipheral-blood
leukocytes via standard techniques. The experiments were
conducted in accordance with the guidelines of the Comite´
Cientı´fico de la Fundacio´n Centro Me´dico de Asturias, and
written informed consent was obtained from each
individual providing biological samples. The pedigrees for
both families are shown in Figure 1. The first patient studied
(II-1, family A; Figure 1) was the second child born to
consanguineous third cousins (coefficient of inbreeding,
F ¼ 1/64). Both parents and his four siblings were healthy,
and there was no significant clinical family history. The
patient exhibited normal development until 2 years of
age. From that age, he experienced failure to thrive and
his skin became dry and atrophic with small light-brownstituto Universitario de Oncologı´a, Universidad de Oviedo, 33006-Oviedo,
e´dico de Asturias, 33193-Oviedo, Spain; 3Universite´ de la Me´diterrane´e,
Genetics. All rights reserved.
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Figure 1. Identification of a Mutation in BANF1 by Exome Sequencing in a Patient with Atypical Progeria
(A) The appearance of both patients included in the study at 1 year of age (left), evidence of progeroid features in patient A at 31 years of
age (top), and evidence of such features in patient B at 24 years (bottom). Clinical characteristics include facial abnormalities due to
severe bone changes, small chin, convex nasal ridge, and prominent eyes. The presence of eyebrows and eyelashes are characteristics
of atypical progeria.
(B) Scheme showing the filtering procedure used for identifying candidate genes in study of this progeroid syndrome, assuming a reces-
sive inheritancemodel. Coding variants were filtered by retaining only those causing amino acid substitution. Common polymorphisms
present in either dbSNP131 or in ten unrelated individual genomes were excluded. Homozygous variants that were present in hetero-
zygosity in both parents were finally selected.
(C) Manhattan plot showing the density of heterozygous variants obtained from exome sequencing data in 50 Kb nonoverlapping
windows of coding-sequence. The density of homozygous variants per window is indicated by black bars. An arrow indicates the pres-
ence of a homozygosity track on chromosome 11. Below is a detailed view of chromosome 11, showing a long stretch of homozygosity
(red bar), and a plot showingmutations present in the patient and themother (red lines), in the patient and the father (green lines), and
in the patient and both parents (black lines).
(D) Pedigrees and results from sequencing of the four candidate gene variants in both families.spots over the thorax, scalp, and limbs. He also developed
a generalized lipoatrophy, severe osteoporosis, and marked
osteolysis. The atrophic facial subcutaneous fat pad and the
marked osteolysis of the maxilla and mandible result in
a typical pseudosenile facial appearance with micrognatia,
prominent subcutaneous venous patterning, a convex
nasal ridge, and proptosis (Figure 1A and Figure S1 available
online). His cognitive development was completely
normal. Despite an initial diagnosis of HGPS or MAD,
some of the clinical features suggested that this patient
could have a distinct progeroid syndrome. The age of the
patient (31 years, which is very unusual given that most
HGPS patients die in their teenage years), his height
(145 cm, underestimated as a result of his scoliosis), the
presence of eyebrows and eyelashes, the persistence of scalp
hair until the age of 12 (which never disappearedThe Amecompletely), the very severe osteolysis (of the mandible,
clavicles, ribs, distal phalanges, and radius), and the absence
of coronary dysfunction, atherosclerosis, or metabolic
anomalies finally led to the diagnosis of atypical progeria.
A second patient (II-1, family B; Figure 1), a 24-year-old
man showing a phenotype almost identical to the index
case (Figure 1A and Figure S2), was also analyzed. Despite
thorough cardiovascular examination (echocardiogram,
stress test, cardiac computed tomography, Doppler study
of supra-aortic trunks), neither of the patients showed signs
of ischemia or atherosclerosis, both cardinal features of
HGPS.16 Moreover, the lack of mutations in LMNA and
ZMPSTE24 would also be consistent with the hypothesis
that these patients have a different progeroid syndrome.
To evaluate this possibility at the molecular level, we first
performed exon enrichment, followed by massivelyrican Journal of Human Genetics 88, 650–656, May 13, 2011 651
parallel sequencing on DNA samples from the proband
(II-1, family A; Figure 1) and both parents. Three micro-
grams of genomic DNA was fragmented and hybridized
with the use a SureSelect Human All Exon Kit (Agilent,
Palo Alto, CA) together with the Paired-End Sample Prepa-
ration Kit from Illumina in accordance with the manufac-
turers’ protocols. The captured DNA fragments were
sequenced with the Genome Analyzer IIx (Illumina, San
Diego, CA), with the use of two lanes per sample and 52
cycles, resulting in more than 60 million paired reads per
sample. Reads were aligned to the reference genome
(GRCh37) with the Burrows-Wheeler Aligner (BWA
0.5.7),17 and SAMtools 0.1.718 was used for removal of
PCR duplicates and initial SNP calling. All single-nucleo-
tide variants were required to have aminimum SNP quality
of 40, supported by reads in both orientations, and to be
no fewer than three bases from an indel. Common variants
present in either dbSNP131 or in ten personal genomes of
Spanish origin were filtered. Homozygous variants were
identified with the use of custom scripts and verified by
visual inspection. More than 98% of the coding exome
was covered by at least one read in the three individuals,
and more than 90% was covered by at least ten reads.
Although these extremely rare diseases can be caused by
dominant de novo mutations, we first assumed an auto-
somal-recessive mode of inheritance because of the
consanguinity of healthy parents. We first searched for
homozygous variants and applied a model of identity by
descent (IBD). Out of the 18,655 coding variants found
in the proband, 8062 produced nonsynonymous changes,
from which 96% were present either in dbSNP131 or in
several unrelated individuals from whom genomic data
were available at our group (Figure 1B). Only four of the
uncommon remaining variants were homozygous in the
proband and heterozygous in the parents. Interestingly,
three of the four candidate genes (BANF1 [MIM 603811],
KRTAP5-11, and AQP11 [MIM 609914]) were located in
a long contiguous stretch of homozygosity on chromo-
some 11q13 (Figure 1C), whereas the fourth one (GGTLC1
[MIM 612338]) was located on chromosome 20p11. SNP
array analysis revealed that the first region contained two
copies in the proband, precluding the occurrence of a large
deletion in this patient. In addition, all nucleotide variants
detected in this region were also present in both the father
and the mother, indicating that this homozygosity track
was not due to uniparental disomy but was independently
inherited from the parents.
The presence of three candidate genes in a small locus of
less than 13 Mb would likely result in linkage disequilib-
rium between the three variants, thus making difficult
the identification of the individual alteration responsible
for this disease. Therefore, we performed PCR amplifica-
tion and capillary sequencing of the four variants
mentioned above in the studied family and in the second
family, with a similar progeroid syndrome and without
mutations in either LMNA or ZMPSTE24. We found that
the affected individual from the second family (II-1,652 The American Journal of Human Genetics 88, 650–656, May 13,family B; Figure 1) had the same homozygous mutation
(chr11:65770755G>A) in BANF1 (NM_001143985.1,
c.34G>A [p.Ala12Thr]) that was originally identified in
the patient from family A, although sequencing of the
coding regions of AQP11, KRTAP5-11, and GGTLC1 did
not reveal additional mutations (Figure 1D and
Figure S3). Even though both families are of different
geographical origins and they did not report any known
relationship with each other, both patients shared
a common homozygous haplotype comprising four SNPs
in BANF1 (rs14157, G/G; rs1786171, C/C; rs1786172,
G/G; rs56984820, /), which suggests the occurrence of
a founder mutation. All nonaffected members from
both families were either heterozygous or did not have
the BANF1 mutation, and sequencing of more than
400 chromosomes from individuals of the Spanish popula-
tion failed to detect this variant, confirming that it is not
a common polymorphism. Together, these data strongly
support the causal role of this mutation in BANF1 as the
genetic alteration responsible for this progeroid syndrome.
BANF1 encodes a protein of 89 amino acids called
barrier-to-autointegration factor 1 (BAF), which forms
dimers and is implicated in nuclear envelope assembly.19
The affected residue (Ala12) has been highly conserved
through evolution from fish to humans (Figure 2A),
suggesting an important role in the structure or function
of this small protein. BAF interacts with DNA as well as
with different proteins,19–21 including lamin A, which is
mutated in HGPS, reinforcing the role of BAF in the
segmental progeroid syndrome exhibited by the patients
described herein. A three-dimensional model of mutant
BAF shows that the mutated residue is located on the
surface of the protein22,23 (Figure 2B). Nevertheless, the
p.Ala12Thr mutation is not predicted to affect BAF dimer-
ization or its binding to either DNA or emerin, raising the
possibility that this amino acid substitution could impair
the interaction with other proteins, its subcellular localiza-
tion, or its stability. For examination of the effect of the
BAF p.Ala12Thrmutation at the protein level, a skin biopsy
was obtained from both patients and from a parent
(I-1, family A) and used to establish cell cultures of primary
dermal fibroblasts. Control cells (AG10803 human skin
fibroblasts) were obtained from the Coriell Cell Repository.
We analyzed BAF expression in primary fibroblasts from
both patients (homozygous for the mutation), from
a heterozygous carrier (I-1, family A), and from control
fibroblasts, using immunoblotting with mouse mono-
clonal anti-BAF (ab88464, Abcam), which recognizes
two bands corresponding to phosphorylated (slower
migrating) and nonphosphorylated (faster migrating)
BAF.24 Fibroblasts homozygous for the p.Ala12Thr muta-
tion had very low levels of BAF protein as compared to
control fibroblasts, whereas heterozygous fibroblasts had
intermediate levels (Figure 2C). Quantitative RT-PCR
experiments using a specific TaqMan expression assay for
BANF1 (Applied Biosystems, Foster City, CA) revealed
that BANF1 mRNA levels were not significantly2011
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Figure 2. Alteration of BAF Structure in Cells Homozygous for the p.Ala12Thr Mutation
(A) Sequence alignment of the first 20 residues of human BAF to its orthologs from the indicated species, showing the evolutionary
conservation of the Ala12 residue (indicated with an arrow).
(B) Three-dimensional model of a BAF dimer (green and orange in the figure) in complex with emerin (blue) and DNA (gray). To generate
the model, the structure of the BAF dimer-emerin complex (PDB 2ODG) was aligned with the structure of a BAF-DNA complex (PDB
2BZF) with the use of PyMOL. The position of the Thr residue in mutant BAF is indicated.
(C) Immunoblot analysis of BAF in control human fibroblasts along with fibroblasts from patients homozygous for the p.Ala12Thrmuta-
tion and from the mother (heterozygous carrier) of the family A patient. The immunoblots shown are representative of three indepen-
dent experiments.
(D) BANF1 mRNA relative levels in fibroblasts homozygous or heterozygous for the p.Ala12Thr mutation, determined by qRT-PCR.
Values correspond to the mean of triplicates. Error bars represent standard deviation of the mean.downregulated in the mutant cells, indicating that this
mutation affects the stability of the protein rather than
having an effect at the mRNA level (Figure 2D).
A morphological analysis of the nuclei from mutant
fibroblasts revealed profound nuclear abnormalities,
including blebs and aberrations previously described in
other laminopathies5–8,25,26 (Figure 3). Immunofluores-
cence analysis using antibodies against lamin A/C and
emerin, interaction partners of BAF and structural constit-
uents of the nuclear lamina,27,28 revealed significant
differences in the subcellular distribution of emerin
between control cells and fibroblasts from these patients
(Figure 3), whereas alterations in lamin A/C distribution
were not evident under the same conditions (Figure S4).
Emerin was specifically located in the nuclear lamina of
normal fibroblasts, whereas in fibroblasts homozygous
for the p.Ala12Thr mutation, emerin lost its nuclear distri-
bution and was found predominantly in the cytoplasm,
with some minor staining in the nuclear lamina.
To further confirm the causal role of the BAF p.Ala12Thr
mutation in this process, we generated an EGFP-BAF protein
by cloning the coding sequence of human BAF in the
polylinker region of pEGFP-C1 (Clontech, Palo Alto, CA).
We transiently transfected mutant fibroblasts with this
expression vector encoding an EGFP-BAF fusion protein,The Ameand confocal microscopy analysis revealed that ectopic
expression of EGFP-BAF in these progeroid fibroblasts
rescued the nuclear abnormalities. Thus, EGFP-BAF-positive
cells recovered a normal nuclear morphology, in contrast to
the aberrations observed in control cells transfected with
EGFP (Figure 4). These findings are consistent with the re-
ported relevance of BAF in nuclear lamina dynamics.29,30
In fact, experimental reduction of BAF by RNAi in human
cells results in the formation of nuclear envelope alterations
and abnormal localization of emerin,29 similar to the find-
ings observed in these progeroid patients. Together, these
results show that the p.Ala12Thrmutation in BAF identified
in patients with this progeroid syndrome causes an
abnormal distributionof components of thenuclear lamina,
which are likely responsible for the nuclear abnormalities
observed in this laminopathy. The phenotypic expression
of laminopathies is highly variable, and although our two
patients have features that are also exhibited in HGPS and
mandibuloacral dysplasia, their clinical findings differ in
several aspects. Neither of our patients has signs of athero-
sclerosis or cardiac ischemia (fatal heart attacks and strokes
at a mean age of 13 years are a common feature of HGPS).
Additionally, ourpatientsdonothave insulin resistance,dia-
betesmellitus, orhypertriglyceridemia, all ofwhichare usual
features ofmandibuloacral dysplasia. Finally, it is remarkablerican Journal of Human Genetics 88, 650–656, May 13, 2011 653
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Figure 3. Nuclear Envelope Alterations in Fibroblasts Homozygous for the p.Ala12Thr Mutation in BAF
Emerin distribution was analyzed by immunofluorescence with the use of an anti-emerin rabbit polyclonal antibody (ab14208, Abcam)
and by confocalmicroscopy (Leica SP2) in primary fibroblasts from the progeroid patient II-1 (family A) and in control fibroblasts. Nuclei
with structural abnormalities can be observed in progeroid fibroblasts.that despite the phenotypic overlapping between patients
with HGPS or mandibuloacral dysplasia and those with the
segmental progeria described herein, the observed differ-
ences are of utmost importance to patients and their fami-
lies. Thus, it seems that those patients with the progeroid
syndrome caused by BANF1 mutation are not at increased
risk of acute myocardial infarcts, cerebrovascular accidents,
or diabetes mellitus. In contrast, they suffer profound skel-
etal abnormalities that affect their quality of life (both
patients experience pain, dysfunction, and disability) and
occasionally may result in life-threatening complications,
such as pulmonary hypertension secondary to severe scoli-
osis. Therefore, palliation of osseous manifestations is
a priority in our patients, given their relatively long lifespan.
In summary, the finding of mutations in BANF1 associ-
ated with a progeroid syndrome may open therapeutic
approaches for patients with this condition, as has been
the case for children with HGPS (ClinicalTrials.gov;
NCT00731016, NCT00425607, NCT00916747).31–33
Furthermore, the fact that BAF is functionally connected
to the nuclear envelope, together with the previous
finding that prelamin A isoforms are accumulated during
normal and pathological aging,5,6,34–36 underscores the
importance of the nuclear lamina for human aging and
may provide newmechanistic insights about this complex,
multifactorial, and universal process.Supplemental Data
Supplemental Data include four figures and can be foundwith this
article online at http://www.cell.com/AJHG/.654 The American Journal of Human Genetics 88, 650–656, May 13,Acknowledgments
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